Dr Nikolaus Marx Highlights Importance of Early Screening for Comorbid Diabetes, CVD
August 27th 2023Nikolaus Marx, MD, professor of medicine/cardiology and head of the Department of Internal Medicine, University Hospital Aachen, Germany, explains the new guidelines on screening for patients with type 2 diabetes and comorbid cardiovascular disease (CVD).
Watch
Dr Javed Butler Highlights Goals, Baseline Patient Characteristics in EMPACT-MI Trial
August 25th 2023With nearly a third of patients post-myocardial infarction (MI) developing heart failure, prevention is very important, said Javed Butler, MD, MPH, MBA, professor of medicine at University of Mississippi, president of the Baylor Scott & White Research Institute.
Watch
Catherine Nester Discusses the BeginNGS Tool for Newborn Rare Disease Screening Awareness
August 25th 2023Catherine Nester, RN, vice president of physician and patient strategies at Inozyme Pharma, highlights the importance of newborn screening for rare diseases and the impact of the BeginNGS diagnostic tool.
Watch
Dr Jennifer Brown Discusses Zanubrutinib Uptake in CLL, SLL
August 23rd 2023Jennifer Brown, MD, PhD, director of the Chronic Lymphocytic Leukemia Center at Dana-Farber Cancer Institute, discussed the uptake of zanubrutinib for the treatment of chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL).
Watch
Sneak Peek at ESC Congress 2023 With Dr Stephen Greene
August 23rd 2023Attendees should look out for results from the STEP HFpEF program and HEART-FID trial at the European Society of Cardiology (ESC) Congress 2023, said Stephen Greene, MD, Duke University Medical Center and the Duke Clinical Research Institute.
Read More
As Incoming CEO, Dr Crystal Denlinger Highlights NCCN Guidelines, Challenges, and Treatment Access
August 23rd 2023Crystal Denlinger, MD, FACP, incoming CEO of the National Comprehensive Cancer Network (NCCN), talks about the organization’s challenges and solutions to keeping up with the ever-changing oncology landscape and improving patient access to guideline-recommended treatments.
Watch
Dr John McMurray: ESC Congress 2023 Has Something for Everyone
August 22nd 2023Ahead of the European Society of Cardiology (ESC) Congress 2023, John McMurray, MD, FRCP, FESC, professor of medical cardiology at the University of Glasgow, previews some themes and important topics that will be discussed at the meeting.
Read More
Dr Gustavo Fonseca on Key Takeaways From an FCS Analysis on Clinical Trial Enrollment
August 19th 2023Gustavo Fonseca, MD, FACP, physician director of clinical research, Florida Cancer Specialists & Research Institute (FCS), discusses the results from a late phase complexity analysis on barriers to clinical trials regarding biopsy requirements.
Watch
Dr Jennifer Gass Provides an Overview of FCS' Next-Generation Sequencing Laboratory
August 16th 2023Jennifer Gass, PhD, FACMG, associate director, Genetics Laboratory, Florida Cancer Specialists & Research Institute, discusses the recent Genetics Laboratory, which focuses on next-generation sequencing (NGS) testing in oncology care.
Watch
Laura Wingate Discusses Patient Education for Biosimilar Switches vs New Starts, Interchangeability
August 15th 2023Greater attention needs to be on educating patients who are switching from a reference product they are successful on to a biosimilar than a patient who is starting a treatment with a biosimilar at the beginning of their disease journey, explained Laura Wingate, executive vice president, Education, Support, & Advocacy, Crohn's & Colitis Foundation.
Watch
Dr Sheila Garland Highlights Lifestyle, Psychological Impacts of Cancer Treatments
August 8th 2023Sheila Garland, PhD, MSc, Memorial University in Newfoundland, Canada talks about the cognitive effects cancer can have on patients, beyond treatment side effects, and the direct impacts these can make on patients’ lives and care.
Watch
Laura Wingate: Education Makes Patients More Confident in Biosimilar Switches
August 3rd 2023There is a right way and a wrong way to inform a patient about a switch from the reference product to a biosimilar, explained Laura Wingate, executive vice president, Education, Support, & Advocacy, Crohn's & Colitis Foundation.
Watch
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
Dr Haley Naik: Improved Medical Education Can Help Reduce Diagnostic Delays of HS
July 30th 2023Some populations face longer diagnostic delays for hidradenitis suppurativa (HS), but medical education can help improve knowledge of common dermatologic diseases and reduce delays in diagnosis, said Haley Naik, MD, FAAD, associate professor of dermatology, University of California, San Francisco, School of Medicine.
Watch
Dr Ghassan Abou-Alfa Expands on HIMALAYA Phase 3 Results, Methods
July 29th 2023Ghassan Abou-Alfa, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, expands on findings that durvalumab plus tremelimumab demonstrated an overall survival benefit at 4 years for certain patients with unresectable hepatocellular carcinoma.
Watch